Association between plasma PCSK9 levels and lipid profile in patients with Parkinson's disease and comparison with healthy subjects.

Jahed, Mohammad Reza; Habibi, Seyed Amir Hassan; Vaseghi, Golnaz; Amiri, Hasan; Montazeri, Hamed; Eshraghi, Azedeh

Jahed, Mohammad Reza; Habibi, Seyed Amir Hassan; Vaseghi, Golnaz; Amiri, Hasan; Montazeri, Hamed; Eshraghi, Azedeh.

Afiliación

Jahed MR; Department of Clinical Pharmacy, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran.
Habibi SAH; Department of Neurology, Movement Disorders Clinic, Rasool Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Vaseghi G; Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Amiri H; Department of Emergency Medicine, School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Sciences, Tehran, Iran.
Montazeri H; Emergency Medicine Management Research Center, Iran University of Medical Sciences, Tehran, Iran.
Eshraghi A; Department of Biotechnology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran.

Curr J Neurol ; 21(4): 236-243, 2022 Oct 07.

Article en En | MEDLINE | ID: mdl-38011467

Palabras clave

High Density Lipoprotein; Low Density Lipoprotein; Parkinson Disease; Proprotein Convertase Subtilisin Kexin; Triglycerides

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Curr J Neurol Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google